Viral Hepatitis Care Network

What Viral Hepatitis Care Network does

Viral Hepatitis Care Network (VIRCAN) is a Toronto-based academic-community healthcare network established in 2016 as an initiative of the Toronto Centre for Liver Disease (TCLD), part of the University Health Network (UHN). It provides publicly funded (OHIP) Hepatitis B and Hepatitis C screening, diagnosis, treatment, and cure services to residents of the Greater Toronto Area, with a particular focus on immigrants from endemic regions and other at-risk populations. The network operates a hub-and-spoke model in which TCLD at UHN serves as the academic hub, though physical clinic operations have consolidated to a single North York location after the permanent closure of Scarborough, Richmond Hill, and Etobicoke sites.

VIRCAN's service platform integrates point-of-care Hepatitis C rapid testing, non-invasive Fibroscan-based fibrosis assessment, individual counselling, and community outreach. It is supplemented by multi-language patient education materials (English and Chinese), GP referral pathways, and a network of community partners spanning community health centres, addiction services, settlement and housing organizations, and Asian-focused nurse-practitioner clinics. Clinical and research staff include Executive Director Camelia Capraru, Scientific Director Dr. Jordan Feld, Medical Director Dr. Joshua Juan, Clinical Director Dr. Karli Moncrief, and Director of Implementation Mia Biondi.

The business model is a publicly funded, not-for-profit clinical program embedded within UHN; revenue is derived from Ontario Health Insurance Plan (OHIP) billings and academic/grant funding, with no private-pay pricing. The GTM motion is community-led, driven by outreach to high-risk populations, partnerships with community health and social-service organizations, and physician referral. The organization signals a strategic ambition toward province-wide hepatitis elimination through the Ontario Hep C Elimination Roadmap and Indigenous-collaboration and implementation leadership functions.

Name

Viral Hepatitis Care Network

Legal name

Viral Hepatitis Care Network

Website

https://vircan.ca

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

VIRCAN is a Toronto-based academic-community healthcare network, operating as an initiative of UHN's Toronto Centre for Liver Disease, that provides publicly funded Hepatitis B and C screening, treatment, and cure services to GTA residents using a hub-and-spoke model and community partnerships.

Ownership category

akta.pro rank

Product category

Hepatology and Liver Disease Care Services

NAICS

Health Care and Social Assistance (62)

akta.pro primary industry

Hepatology (Viral Hepatitis) (HLAKAGAC)

akta.pro secondary industries

Hepatology & Liver Disease (HLAKAEAB), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL)

Keywords

• Viral hepatitis treatment
• Liver disease care
• Hepatitis screening services
• Community hepatology clinics
• Fibroscan liver assessment

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Publicly Funded Healthcare Services: VIRCAN is an initiative of the Toronto Centre for Liver Disease, part of the University Health Network (UHN), providing publicly funded liver-related healthcare services in Ontario, Canada. Services are covered through provincial health insurance (OHIP).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

VIRCAN operates a network of community-based liver clinics across the Greater Toronto Area providing Hepatitis B and Hepatitis C screening, point-of-care testing, individual counselling, and comprehensive viral hepatitis care from diagnosis to treatment to cure. Services are delivered through a hub-and-spoke model coordinated by the Toronto Centre for Liver Disease at the University Health Network (UHN).

Product overview

VIRCAN (Toronto Viral Hepatitis Care Network) is a structured academic-community partnership based at the Toronto Centre for Liver Disease (TCLD) that provides a unified care platform for viral hepatitis. The core offering consists of a network of community-based liver clinics across the Greater Toronto Area offering Hepatitis B and Hepatitis C screening, testing, and treatment services. The platform integrates individual counselling, point-of-care testing, and non-invasive fibrosis assessment (Fibroscan®), complemented by community outreach and educational materials including GP brochures and patient flyers in multiple languages. VIRCAN's hub-and-spoke model positions TCLD at UHN as the central coordination site supporting distributed community-based treatment centres.

Differentiator

Problem solved

Functional benefit

Products and services

• VIRCAN Liver Clinics A network of community-based liver clinics across the Greater Toronto Area providing individual counselling, point-of-care Hepatitis C testing, Fibroscan non-invasive fibrosis assessment, and comprehensive viral hepatitis care for residents of the GTA.
• Hepatitis B Screening and Care Screening, diagnosis, vaccination, and management services for Hepatitis B virus (HBV), including treatment to prevent progression to cirrhosis and liver cancer, targeted at at-risk populations and immigrants from endemic regions.
• Hepatitis C Screening and Care Point-of-care testing and comprehensive curative treatment for Hepatitis C virus (HCV), offering screening for at-risk populations including the 1945-1975 birth cohort, individuals with injection drug use history, and those exposed to blood products before 1992.
• Community Outreach Services Health education, promotion, and outreach services delivered in communities across the Greater Toronto Area to eliminate barriers to viral hepatitis screening, testing, and treatment participation.

Quantifiable outcome

• Over 95% cure rates for Hepatitis C with modern antiviral therapies
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• University Health Network (UHN)coreStrategic or Co-development PartnerUHN is the parent organization hosting the Toronto Centre for Liver Disease, which serves as VIRCAN's central coordination site. VIRCAN is an initiative of TCLD part of UHN.
• Toronto Centre for Liver Disease (TCLD)coreStrategic or Co-development PartnerTCLD is the academic medical centre that implements VIRCAN's integrated care model. It serves as the hub in the hub-and-spoke network.
• Toronto General & Western Hospital FoundationcoreStrategic or Co-development PartnerFoundation partner supporting the liver disease programs at UHN.
• Carea Community Health CentreminorStrategic or Co-development PartnerCommunity health centre partner in the VIRCAN network providing community-based care.
• Breakaway Addiction ServicesminorStrategic or Co-development PartnerAddiction services partner providing services to populations at risk for viral hepatitis through substance use.
• St. Stephen's Community HouseminorStrategic or Co-development PartnerCommunity house partner providing housing, homeless services, and newcomer services with connections to VIRCAN.
• Hong Fook Connecting Health Nurse Practitioner-Led ClinicminorStrategic or Co-development PartnerNurse practitioner-led clinic partner serving Asian communities.
• Walking With You Cancer Caring GroupminorStrategic or Co-development PartnerCancer caring group partner in the VIRCAN network.
• Homeless ConnectminorStrategic or Co-development PartnerOrganization connecting homeless individuals to health services including VIRCAN hepatitis screening.
• University SettlementminorStrategic or Co-development PartnerCommunity settlement organization partner providing services to newcomers and community members.
• Seaton HouseminorStrategic or Co-development PartnerHomeless shelter and support services partner.
• Vision Infinite FoundationminorStrategic or Co-development PartnerFoundation partner in the VIRCAN network.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Others

• Canadian Liver Foundation: National charity focused on liver disease research, education, and patient support. Comparable to VIRCAN's mission around awareness, screening, and education for liver disease, though operating at a national advocacy level rather than as a care provider.
• CATIE (Canada's source for HIV and hepatitis C information): National knowledge-exchange organization providing educational resources on HIV and hepatitis C. Comparable as a complementary information and educational resource in the Canadian viral hepatitis ecosystem that VIRCAN's patient-facing materials align with.
• Action Hepatitis Canada: National coalition working toward elimination of viral hepatitis in Canada. Comparable to VIRCAN as a stakeholder in the public-health hepatitis elimination movement, though it is an advocacy organization rather than a care provider.

Regional players

• BC Centre for Disease Control: Provincial public-health organization that runs hepatitis programs and harm-reduction services in British Columbia. Comparable to VIRCAN as a public-health-anchored viral hepatitis care delivery network serving a defined Canadian geography.
• Ottawa Hospital Viral Hepatitis Program: Academic hospital-based hepatitis program serving the Ottawa region within Ontario. Compares to VIRCAN as another Ontario-based academic specialty program offering HBV/HCV diagnosis and treatment, though without VIRCAN's explicit community-spoke model.
• Pacific Hepatitis C Network: British Columbia-based hepatitis C patient and community organization. Comparable to VIRCAN in its community-driven orientation toward hepatitis C awareness and access, though it operates as a community network rather than a clinical service provider.
• Casey House: Toronto specialty hospital focused on HIV and complex care, with overlap in hepatitis B/C screening and treatment for populations with overlapping risk profiles. Functions as a complementary community-care provider in the GTA.

Direct peers

• Maple Leaf Medical Clinic: Toronto-based specialty clinic offering care for HIV, hepatitis B/C, and related infectious diseases. Directly comparable to VIRCAN as a community-based specialty clinic serving similar high-risk populations in the GTA with overlapping patient cohorts.
• Toronto Centre for Liver Disease (TCLD): TCLD is the parent academic hub at UHN that VIRCAN is built around. It shares the same clinicians, research portfolio, and patient population for viral hepatitis, and is the central coordination site for VIRCAN's hub-and-spoke network.

Emerging players

• San Francisco Hep B Free: City-wide hepatitis B screening and education campaign in San Francisco. Comparable to VIRCAN as a model of community-based viral hepatitis screening and outreach targeting high-risk immigrant populations, demonstrating how the academic-community partnership model can be replicated in other cities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/vircan_ca
• Facebookfacebook.com/VircanCanada
• LinkedInca.linkedin.com/company/vircan

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Viral Hepatitis Care Network